AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features

Leukemia

Volumn 23, Issue 5, 2009, Pages 934-943

  Haferlach, T ^a   Kohlmann, A ^a   Klein, H U ^b   Ruckert, C ^b   Dugas, M ^b   Williams, P M ^c   Kern, W ^a   Schnittger, S ^a   Bacher, U ^d   Loffler H ^e   Haferlach, C ^a  

^a MLL MUNICH LEUKEMIA LABORATORY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; PROTEIN GPR 124; PROTEIN KINASE PIM 1; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CELL STRUCTURE; CHROMOSOME 11P; CHROMOSOME 13P; CHROMOSOME 16; CHROMOSOME ABERRATION; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; ERYTHROPHAGOCYTOSIS; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MALE; MYELOID PROGENITOR CELL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 67349225649     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.388     Document Type: Article

References (55)

1. Bloomfield CD, Shuma C, Regal L, Philip PP, Hossfeld DK, Hagemeijer AM et al. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer 1997; 80 (11 Suppl): 2191-2198.
2. Schoch C, Kern W, Schnittger S, Hiddemann W, Haferlach T. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): An analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 2004; 18: 120-125.
3. Swansbury GJ, Lawler SD, Alimena G, Arthur D, Berger R, Van den BH et al. Long-term survival in acute myelogenous leukemia: A second follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer Genet Cytogenet 1994; 73: 1-7.
4. Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W et al. Global approach to the diagnosis of leukemia using gene expression profiling. Blood 2005; 106: 1189-1198.
5. Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W et al. Molecular characterization of acute leukemias by use of microarray technology. Genes Chromosomes Cancer 2003; 37: 396-405.
6. Schoch C, Kohlmann A, Schnittger S, Brors B, Dugas M, Mergenthaler S et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci USA 2002; 99: 10008-10013.
7. Gilliland DG. Hematologic malignancies. Curr Opin Hematol 2001; 8: 189-191.
8. Jaffe ES, Stein H, Vardiman JW. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001.
9. Gervais C, Murati A, Helias C, Struski S, Eischen A, Lippert E et al Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: An integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogenetique hematologique. Leukemia 2008; 22 1567-1575.
10. Troke PJ, Kindle KB, Collins HM, Heery DM. MOZ fusion proteins in acute myeloid leukaemia. Biochem Soc Symp 2006; 73): 23-39.
11. Jacobson S, Pillus L. Modifying chromatin and concepts of cancer. Curr Opin Genet Dev 1999; 9: 175-184.
12. Kitabayashi I, Aikawa Y, Nguyen LA, Yokoyama A, Ohki M. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J 2001; 20: 7184-7196.
13. Schmidt HH. MYST3/CREBBP (MOZ/CBP) and CREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13). Genes Chromosomes Cancer 2005; 42: 207-208.
14. Stark B, Resnitzky P, Jeison M, Luria D, Blau O, Avigad S et al. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13) - case report and review of the literature. Leuk Res 1995; 19: 367-379.
15. Chaffanet M, Gressin L, Preudhomme C, Soenen-Cornu V, Birnbaum D, Pebusque MJ. MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer 2000; 28: 138-144.
16. Coulthard S, Chase A, Orchard K, Watmore A, Vora A, Goldman JM et al Two cases of inv(8)(p11q13) in AML with erythrophagocytosis: A new cytogenetic variant. Br J Haematol 1998; 100: 561-563.
17. Liang J, Prouty L, Williams BJ, Dayton MA, Blanchard KL. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. Blood 1998; 92: 2118-2122.
18. Panagopoulos I, Teixeira MR, Micci F, Hammerstrom J, Isaksson M, Johansson B et al. Acute myeloid leukemia with inv(8)(p11q13). Leuk Lymphoma 2000; 39: 651-656.
19. Panagopoulos I, Fioretos T, Isaksson M, Samuelsson U, Billstrom R, Strombeck B et al. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum Mol Genet 2001; 10: 395-404.
20. Glassman AB, Hayes KJ. Translocation (11;16)(q23;p13) acute myelogenous leukemia and myelodysplastic syndrome. Ann Clin Lab Sci 2003; 33: 285-288.
21. Haferlach T, Bacher U, Kern W, Schnittger S, Haferlach C. Diagnostic pathways in acute leukemias: A proposal for a multimodal approach. Ann Hematol 2007; 86: 311-327.
22. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-458.
23. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-625.
24. Borrow J, Stanton Jr VP, Andresen JM, Becher R, Behm FG, Chaganti RS et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 1996; 14: 33-41.
25. Schmidt HH, Strehl S, Thaler D, Strunk D, Sill H, Linkesch W et al RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: Breakpoint cluster region and clinical implications. Leukemia 2004; 18: 1115-1121.
26. Murati A, Adelaide J, Quilichini B, Remy V, Sainty D, Stoppa AM et al New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias. Haematologica 2007; 92: 262-263.
27. Kohlmann A, Schoch C, Dugas M, Rauhut S, Weninger F, Schnittger S et al. Pattern robustness of diagnostic gene expression signatures in leukemia. Genes Chromosomes Cancer 2005; 42: 299-307.
28. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4 249-264.
29. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article3.
30. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 1995; 57: 289-300.
31. Vapnik VN. The Nature of Statistical Learning Theory 1995.
32. Metzeler KH, Hummel M, Bloomfield CD, Spiekermann K, Braess J, Sauerland MC et al. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood 2008; 112: 4193-4201.
33. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ et al A network-based analysis of systemic inflammation in humans. Nature 2005; 437: 1032-1037.
34. Becher R, Haas OA, Graeven U, Bettelheim P, Ambros P, Fridrik M et al Translocation t(8;16) in acute monocytic leukemia. Cancer Genet Cytogenet 1988; 34: 265-271.
35. Velloso ER, Mecucci C, Michaux L, Van OA, Stul M, Boogaerts M et al Translocation t(8;16)(p11;p13) in acute non-lymphocytic leukemia: report on two new cases and review of the literature. Leuk Lymphoma 1996; 21: 137-142.
36. Zandecki M, Lai JL, Mazingue F, Lepelley P, Chassaing O, Farriaux JP et al. Congenital acute monoblastic leukemia with double translocation (8;16) (p11;p13) and (16;20) (q13;p13). Nouv Rev Fr Hematol 1988; 30: 247-250.
37. Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350: 1605-1616.
38. Debernardi S, Lillington DM, Chaplin T, Tomlinson S, Amess J, Rohatiner A et al. Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer 2003; 37: 149-158.
39. Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, Song G et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood 2004; 104: 3679-3687.
40. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350: 1617-1628.
41. Armstrong SA, Staunton JE, Silverman LB, Pieters R, Den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41-47.
42. Kohlmann A, Schoch C, Dugas M, Schnittger S, Hiddemann W, Kern W et al. New insights into MLL gene rearranged acute leukemias using gene expression profiling: Shared pathways, lineage commitment, and partner genes. Leukemia 2005; 19: 953-964.
43. Mitelman F, Heim S. Quantitative acute leukemia cytogenetics. Genes Chromosomes Cancer 1992; 5: 57-66.
44. Bernasconi P, Orlandi E, Cavigliano P, Calatroni S, Boni M, Astori C et al. Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin's lymphoma. Haematologica 2000; 85: 1087-1091.
45. Quesnel B, Kantarjian H, Bjergaard JP, Brault P, Estey E, Lai JL et al. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): A report on 25 cases and review of the literature. J Clin Oncol 1993; 11: 2370-2379.
46. Heim S, Avanzi GC, Billstrom R, Kristoffersson U, Mandahl N, Bekassy AN et al. A new specific chromosomal rearrangement, t(81;16) (p11;p13), in acute monocytic leukaemia. Br J Haematol 1987; 66 323-326.
47. Michallet AS, Lai JL, Bauters F, Fenaux P, Quesnel B. A new case of therapy-related acute myeloid leukaemia with t(8;1 6)(p11;p13). Br J Haematol 1998; 100: 801-802.
48. Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W, Haferlach T. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 2003; 102: 2395-2402.
49. Bacher U, Kern W, Schnittger S, Hiddemann W, Schoch C, Haferlach T. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients. Ann Hematol 2005; 84: 785-791.
50. Haferlach T, Schoch C, Schnittger S, Kern W, Loffler H, Hiddemann W. Distinct genetic patterns can be identified in acute monoblastic and acute monocytic leukaemia (FAB AML M5a and M5b): A study of 124 patients. Br J Haematol 2002; 118: 426-431.
51. Camos M, Esteve J, Jares P, Colomer D, Rozman M, Villamor N et al. Gene expression profiling of acute myeloid leukemia with translocation t(8;1 6)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression. Cancer Res 2006; 66: 6947-6954.
52. Murati A, Gervais C, Carbuccia N, Finetti P, Cervera N, Adelaide J et al. Genome profiling of acute myelomonocytic leukemia: Alteration of the MYB locus in MYST3-linked cases. Leukemia 2009; 23: 85-94.
53. Zhang H, Rider Jr SD, Henderson JT, Fountain M, Chuang K, Kandachar V et al. The CHD3 remodeler PICKLE promotes trimethylation of histone H3 lysine 27. J Biol Chem 2008; 283: 22637-22648.
54. Saether T, Berge T, Ledsaak M, Matre V, Im-Kristiansen AH, Dahle O et al. The chromatin remodeling factor Mi-2alpha acts as a novel co-activator for human c-Myb. J Biol Chem 2007; 282: 13994-14005.
55. Yanagisawa H, Nagasawa T, Kuramochi S, Abe T, Ikawa Y, Todokoro K. Constitutive expression of exogenous c-myb gene causes maturation block in monocyte-macrophage differentiation. Biochim Biophys Acta 1991; 1088: 380-384.